RADIENT PHARMACEUTICALS CORP (RXPC)
Radient Pharmaceuticals Corporation is focused on developing and delivering cancer diagnostic tests. Radient's Onko-SureTM IVD cancer test is used to guide decisions regarding patient treatment, which can include decisions to refer patients to specialists, perform additional testing or assist in the selection of cancer therapy.
0
(0%)
| Today's High: | 0.0001 | Volume: | 0 |
| Today's Low: | 0.0001 | Avg Vol: | 769,857 |
| 52 Week High: | 0.0004 | Bid (size): | 0 |
| 52 Week Low: | 0.0001 | Ask (size): | 0 |
To see the headquarters in Google Street View &trade, drag this yellow guy:
over to the red pointer: 
Contact Information:
| Business Address: | 2492 Walnut Avenue, Suite 100, Tustin, CA 92780-7039, United States |
| Mailing Address: | - |
| Phone: | 714-505-4461 |
| Fax: | 714-505-4464 |
| Website: | http//www.radient-pharma.com |
Company Details:
| Symbol: | RXPC |
| SIC: | - |
| State location: | CA |
| Sector: | - |
| State of Inc: | DE |
| Employees: | 10 |
| Type: | - |
Key executives:
| Name | Age | Position |
|---|
Radient Pharmaceuticals Corporation (PINK:RXPC) Trying to Look Good December 6, 2011
Radient Pharmaceuticals Corporation (PINK:RXPC) recently issued some press releases aimed at giving some hope to shareholders, and the market has responded with some increase in price. read more
Radient Pharmaceuticals Corporation (PINK:RXPC) Taking a Breather from Its Free Fall November 29, 2011
In the latest several trading sessions Radient Pharmaceuticals Corporation (PINK:RXPC) has managed to close up. It's not that they have found some magical solution to their problems, though. read more
Radient Pharmaceuticals Corporation (PINK:RXPC) Recovers a Bit on a Distribution Agreement October 11, 2011
Radient Pharmaceuticals Corporation (PINK:RXPC) is the developer and marketer of a non-invasive cancer blood test kit. The company is not in a good place right now, but the last several sessions may bring some hope to shareholders. read more
Radient Pharmaceuticals Corporation (PINK:RXPC) Keeps On Crashing Hard September 9, 2011
Radient Pharmaceuticals Corporation (PINK:RXPC) is now in the sub-penny zone. On Wednesday, RXPC closed at $0.008, and yesterday it dropped further to $0.0054. read more
| Post # | Subject | Re | Name | Date |
|---|---|---|---|---|
| There are no comments. | ||||
